Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies.
Bojana JovanovicSarah E ChurchKara M GormanKhrystyna NorthEdward T RichardsonMolly DiLulloVictoria AttayaJulie KasparianAyesha Mohammed-AbreuGregory KirknerMelissa E HughesNancy U LinElizabeth A MittendorfStuart J SchnittSara M TolaneyShom GoelPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Our study contributes new insights into biomarker utility for identifying suitable TNBC therapies and the intercorrelations between genomic, transcriptomic, protein, and cellular biomarkers. Additionally, our rich data resource can be used by other researchers to explore the interplay between DNA, RNA, and protein biomarkers in TNBC.